ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DUKE Duke Capital Limited

31.75
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Duke Capital Limited LSE:DUKE London Ordinary Share GG00BYZSSY63 ORDS NPV
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 31.75 118,876 08:00:00
Bid Price Offer Price High Price Low Price Open Price
31.50 32.00 31.75 31.75 31.75
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Unit Inv Tr, Closed-end Mgmt 31.06M 19.59M 0.0472 6.73 131.9M
Last Trade Time Trade Type Trade Size Trade Price Currency
10:16:15 O 13,500 31.66 GBX

Duke Capital (DUKE) Latest News

Duke Capital (DUKE) Discussions and Chat

Duke Capital (DUKE) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
09:16:1631.6613,5004,274.10O
09:09:0832.0061.92O
09:00:3931.90626199.69O
08:56:5331.8515,0004,777.50O
08:56:1131.514915.44O

Duke Capital (DUKE) Top Chat Posts

Top Posts
Posted at 22/4/2024 09:20 by Duke Capital Daily Update
Duke Capital Limited is listed in the Unit Inv Tr, Closed-end Mgmt sector of the London Stock Exchange with ticker DUKE. The last closing price for Duke Capital was 31.75p.
Duke Capital currently has 415,427,000 shares in issue. The market capitalisation of Duke Capital is £131,898,073.
Duke Capital has a price to earnings ratio (PE ratio) of 6.73.
This morning DUKE shares opened at 31.75p
Posted at 07/3/2024 11:31 by riverman77
Looks like 2 very good exits - surprised no reaction at all to the share price, but think this is back in buying territory after recent weakness.
Posted at 06/3/2024 10:55 by senttothegallows
TIDMDUKE

RNS Number : 7443D

Duke Royalty Limited

01 July 2021

1 July 2021

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")



-- The EUR10 million royalty is a 30-year senior secured financing, with monthly payments commencing immediately in July 2021 on Duke's typical investment terms.
Posted at 06/3/2024 07:23 by senttothegallows
Successful Exit of Investment in Fairmed Healthcare AG



Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to announce the successful exit of its investment in Fairmed Healthcare AG ("Fairmed"), a Switzerland-based provider of high-quality generic prescription medicines, over-the-counter pharmaceuticals, dermocosmetics and dietary supplements in various EU countries.



Overview



· Headline cash consideration of €11.4 million, providing Duke with additional liquidity for new deployments into its pipeline of long-established, profitable businesses

· Payment of €6.0 million has been received with the balance of €5.4 million to be paid by 31 March 2024

· This represents the seventh exit for Duke, delivering its sixth profitable exit. The exit of Fairmed is at the upper end of the expected rate of return for Duke with no equity participation

· Duke's financing solution enabled Fairmed's management team to retain its minority equity stake, while receiving the capital to support the expansion of its product portfolio

· Duke's investment exit was facilitated by Fairmed's majority owner, Strides Pharma Global Pte Ltd, a fully owned subsidiary of Strides Pharma Science Limited ("Strides"). The prepayment of Duke's investment paves the way for Strides to initiate the next phase of its European strategy, utilising Fairmed to expand and strengthen its presence in the region
Posted at 07/2/2024 06:11 by carcosa
I first bought into DUKE February 2021. I liked the idea of a what was being touted as long terms loans into well researched and run businesses. It seemed relatively low risk, high return and a growth business for DUKE.

Clearly when the pandemic struck practically all businesses were in survival mode and DUKE managed it well.

Around the same time DUKE were taking on equity stakes which to me seemed a reasonable outcome as a consequence of the pandemic. Other businesses also did the same thing e.g. Avation and others. But those equity stakes were supposed to be a short term situation to get over the hump post covid.

Subsequently from the few customers DUKE has that issue financial reports mostly through Companies House some were and had been for years in a distressed situation. One or two clearly rely on DUKE to stay in business. In the long term it 'should' be okay because progress over many years will sort themselves out. However these business's were struggling before DUKE came along and I started to question the robustness (or their parameters) of their due diligence research.

The question that is often raised is why would a business pay extraordinary interest over and above the normal financing options. Duke has certainly marketed their advantages which also included not taking equity stakes, having board representation etc., However it they were such a great option then they should have been signing up new customers by the month.

Some months ago I stated that I saw Duke as being a quasi venture capitalist. For example they have deals whereby they have committed several follow on funds to an investee.

Following this 'rebranding' by Duke I am very much of the belief that that is what Duke is turning toward. 30% equity stakes is a very different proposition to how Duke started out.


Whilst I was okay with sitting back and collecting the dividends, seeing it as a bit of a passive income stream the company has changed, in my opinion, to a venture capitalist company or a investment company; much higher risk. Not what I signed up for. Hence I have been selling out of my reasonably large position since September last year and finally sold the last of my shares earlier this week. I just see better opportunities elsewhere.

On a wider picture falling interest rates will make Duke more valuable as a shareholder and indeed the investee companies should mostly benefit from a reducing inflation/bank rate so anyone who sticks with Duke for a few years is likely to be ok with it IMO.

Bye :-)
Posted at 22/11/2023 12:43 by rogerrail
Is that capital appreciation of the net assets or the share price ? does the share price really matter if earnings of 1.95p per share exceed the dividends of 1.4p per share?
Posted at 13/7/2023 11:22 by clive7878
Future pe of 9 with a 8% divi to support the share price.
But will the share price get back up to the dizzy heights of 45p per share?
The write up in the IC last week was encouraging,
but then so have others that have not moved the share price upwards.
Posted at 12/4/2023 06:12 by carcosa
Just because a company has profitable operations does not mean it cannot go bankrupt.

High debt: Even if a company is profitable, it may still have a significant amount of debt which unsurprisingly tends to be a feature of Duke's business. If the company is unable to service its debt obligations, it may go out of business.

Poor cash flow management: Again, a company may have profitable operations, but if it doesn't manage its cash flow effectively, it may run out of money to pay its bills and employees . This can ultimately lead to bankruptcy.

There are other somewhat less likely issues such as if a company is facing a costly legal battle or lawsuit, it can deplete its resources and ultimately lead to bankruptcy, even if it has profitable operations.

Market conditions: Changes in the market or industry can lead to decreased demand or increased competition, which can cause a decline in profits and eventually lead to bankruptcy. i.e. a declining profitable business.

Mismanagement: Poor management decisions, such as expanding too quickly or investing in unprofitable ventures, can lead to financial difficulties and ultimately result in bankruptcy, despite having profitable operations in the past.

In a similar vein is Lynx Equity (UK). After Duke handed out another 1.5m (Total 15m) follow on to keep the lights on in March 2022 by July 2022 the company only had 0.27m in cash. Now that would be fine if they had spent most of it on aquiring something but in actual fact their investment interests went from 13m to 11.7m.

So in reality that was a loss of 1.3m + 1.5m = 2.8m which roughly concurs with an increase in their profit and loss reserve; now standing at 9.2m

However they also have 10.6m in debtors - They often appear to have a very large debtor book so its a relatively stable figure fwiw. This leads to a positive and healthy positive 11.2m in net assets (down from 16.7m the year before on a current basis. However factoring in the 15.2m owed longer term (mostly to Duke I assume) it results in a negative equity of 4m.

Now if Lynx get to a profitable state then the long term nature of Duke's loan is nothing to be overly concerned about. However, that is a big 'if'

Within the accounts they state that the company is dependent on the company's ultimate parent undertaken and that they believe finances will be available if required to maintain the going concern basis.

So overall yet another (long term) poor business Duke are involved with which again makes me question their screening process in the early days of the company.

However...whilst Lynx appears to be much worse state than even Trimate, Lynx is a subsidiary of a huge company based in the US called Lynx Equity hxxps://www.lynxequity.com/portfolio/ which in itself is a very very interesting company. With such a thriving parent company we don't know what (if any) guarantees they may have provided for Duke, or if it suits them to have an overseas subsidiary to be making a loss. It just gets more complicated and us shareholders will never be in a position to evaluate the risk of Lynx Equity (UK) being in Duke's portfolio.

But lets not get carried away. Even if Trimate was to collapse (and I am not saying it will) the overall thrust of my concern is why did Duke enter into such partners to begin with. Was Trimate seriously the best they could find at the time? As a consequence Duke is now a significant equity holder which is not what us investors signed up for. It raises concern as to the quality of the portfolio. The latter partners, from what I can tell, are worlds above in terms of quality businesses than the early ones.

I reckon current run rate is 6m up from Dukes last reported 5.6. It's one thing to invoice for that amount it's quite another to get it paid. On that front it was very pleasing to see a reduction in receivables of 10m reduce to 3m in the last accounts. Should be remembered that a further 2.2m cash is scheduled to be received before before 30 June 2023 from the Riverboat sale. So it appears Duke are doing a great job of getting paid.


The 6% collar sounded a great idea before inflation became a household word again. Without new business the most Duke's revenue can increase is significantly below the current inflation rate. Profitability could decline in having to pay increased interest of Duke's debt.

Having said all of that, the current share price for Duke seems well below that of what even the most realistic pessimist could justify and over the long term inflation/interest rates are forecast to decline anyway.

You have to start asking whether or not todays share price is offering exceptional value.



Misc:
BTG. I meant 2021 not 2011. Typo. Sorry. Imagine what would happen if you went through Duke's business with such an eye on their figures as opposed to mine!

podgyted: Yes I moved away from Stocko a few years ago. Have reduced by forum postings considerably over the last few years. Occasionally post on TLF & Twitter. Still miss the TMF days lol!
Posted at 12/12/2022 08:05 by cwa1
Refinance and Upsize of Credit Facility to £100 million on
Improved Terms with Fairfax Financial



Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America , is pleased to announce that it has entered into a new £100 million credit facility agreement (the "New Credit Facility") with Fairfax Financial Holdings Limited and certain of its subsidiaries ("Fairfax").



The material terms of the New Credit Facility are as follows:



· Term facility of up to £100 million to replace Duke's existing £55 million term and revolving facilities

· Five-year term, expiring in January 2028 with a bullet repayment on expiry and no amortisation payments during the five-year term

· Interest rate equal to SONIA plus 5.00% per annum, which represents an improvement of 225bps on Duke's existing rate of SONIA plus 7.25%

· As part of the deal, Duke will issue 41,615,134 warrants to Fairfax with a five-year maturity and strike price of 45 pence reflecting the strategic nature of the deal

· Initial drawdown of the New Credit Facility expected to occur in mid/late January 2023 coinciding with the expiry of the non-call period enshrined in Duke's existing credit facilities



The New Credit Facility will provide Duke with a significant amount of additional liquidity and will push out the Company's requirement for additional equity capital. Furthermore, the New Credit Facility comes at a lower cost to the Company's existing credit facility thereby having an immediate and material impact on the free cash flow of the Company.



Neil Johnson, CEO of Duke Royalty, said:



"I am delighted to announce this upsized credit facility with Fairfax on improved terms for Duke shareholders. Fairfax is an internationally recognised and well respected company. Both Duke and Fairfax have similar philosophies of investing in a supportive way over the long term and I believe that this is the start of a long standing and mutually beneficial relationship.



"The upsizing of the New Credit Facility will allow Duke to accelerate its growth and deployment schedule without any near-term equity dilution. More strategically, Fairfax and Duke believe our partnership can benefit more businesses looking for long-term, flexible capital solutions by increasing Duke's capital base and diversification, as well as benefit Duke's shareholders through higher free cash flow per share."



Prem Watsa, Chairman and CEO of Fairfax, said:



"We are impressed with the degree to which Duke's investing philosophy aligns with our own - focusing on lending to established, profitable, cash-generating, well-managed companies, with incentivised management teams. We are delighted to be partnering with Duke and believe that there is a large group of companies that can benefit from Duke's long-term flexible support."
Posted at 17/7/2022 10:09 by btgman
Looking at the current yield at 8% I still have a view that share price is undervalued but where should it be?

Duke Share price at varying yields
8%=32.50p
7.5%=37.33p
7%=40.00p
6.5% 43.07p
6%=46.67p
5.5%=50.9
5%=56p


There are many things to consider and to compare against but all of the above are higher than the FTSE 100 average:-

Average FTSE 100 yield is under 4%
Highest is circa 7.5% tobacco companies
Lowest 2% with a small number paying nothing


There are stocks around in the FTSE 250 paying 9%+ but I would argue the share price is likely to be more volatile than Duke in the current climate.

Duke have 30 year contracts in place with over 20 Royalty Partners linked to turnover across multiple sectors and countries with positive royalty kickers likely in September 2022 results announcement.

Hidden benefits also exist with potential for over £30m of exit fees as Royalty partners exit at some point. Recycling of this cash and the compounding effect is powerful as highlighted previously.

Finally we have many equity stakes in our Royalty partners valued in accounts at circa £3.5m upside for this is quite significant.


So back to original question where should share price be I think 6% would be a decent rate of dividend return and given the 6% kickers and equity stakes I don't feel that would be challenging which puts Duke share price target at 46.67p v the current 32.5p

AIMHO
GLA
BTG
Posted at 27/4/2021 15:46 by btgman
Really disappointed to have missed the IC Forum just had something else on. Once the funds are re-invested Duke share price should kick on. I suspect we should be hearing news fairly soon

AIMHO
GLA
BTG
Duke Capital share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock